October 2015: Dividend Income, Trading Activity and Portfolio Snapshot

Every month I am going to be providing a breakdown of the dividend income received from my shares. The overall monthly total will be included on the main “Dividends Received” page.

• Amlin--£11.26
• Final dividend payment. I sold position in September.
• Diageo--£24.08
• Bought 1 new share
• GlaxoSmithKline--£37.05
• Bought 2 new shares
• HSBC--£18.82
• Bought 3 new shares
• Interserve--£22.59
• Bought 3 new shares
• Old Mutual--£8.64
• Bought 3 new shares
• PZ Cussons--£9.22
• Bought 3 new shares

Total for October: £131.65 ($203.50).

May 2015: Dividend Income, Trading Activity and Portfolio Snapshot

Every month I provide a breakdown of the dividend income received from my investments as well as various updates on my goal progress and other portfolio activity for the month.

• Amlin--£42.71
• Bought 8 new shares.
• Banco Santander--£10.18
• Bought 2 new shares. The last of the higher dividend payouts.
• Hansteen Holdings--£34.20
• Bought 27 new shares.
• Interserve--£43.40
• Bought 6 new shares.
• Old Mutual--£19.88
• Bought 8 new shares.

Total for May: £150.37 ($229.83).

To see my overall dividend totals and those from previous months see my Dividends Received page.

BUY: Old Mutual--A great growth and income company

Price: 187.95p
Shares: 318
Predicted annual dividend income: £27.89

There are an awful lot of insurers in the FTSE 100. however, one of the lesser known ones is the African-focused Old Mutual. Although much of its income is from Africa it also includes large income from Asia and Europe.

Old Mutual has been of interest to me for some time. It seemed to combine the qualities of a growth and an income stock beautifully. Consequently, with share prices declining across the board I felt it time to finally push some funds in their direction. But why?

January 2015: Dividend Income and Trading Activity

Every month I am going to be providing a breakdown of the dividend income received from my shares. The overall monthly total will be included on the main “Dividends Received” page.

• GlaxoSmithKline--£35.91
• Bought 2 more shares.

Total for January: £35.91 ($54.09).

BUY: GlaxoSmithKline price drop buy...Part 3

Price: 1514.945
Shares: 30
Projected annual dividend income: £24 (this purchase) and £121.60 (entire holding)

That's right folks. Another GSK buy in July. So far 100% of my investing funds has gone to the pharmaceutical giant.

In fact, such is the GSK buying frenzy here it now composes nearly a third of my entire portfolio (see current breakdown below and--for a more up-to-date portfolio weighting--visit my Holdings page).

I am rather surprised to find myself tucking away so much of my funds in GSKs direction. indeed, the money had already pretty much been earmarked for one of a number of other investing avenues including a potential new portfolio addition (possibly BAE Systems, Marston's or Old Mutual) or top up (such as SSE or HSBC).